No Data
No Data
Proteomics International Laboratories Taps French Distributor for Diabetic Kidney Disease Test
Proteomics International Laboratories (ASX:PIQ) signed a five-year exclusive deal with diagnostic test distributor firm Eurobio Scientific to market and sell the PromarkerD diabetic kidney disease tes
Proteomics International Issues 3.04 Million Options to Employees; Shares Up 7%
Proteomics International Laboratories (ASX:PIQ) issued 3,040,000 options to employees under its incentive scheme, according to a Monday filing with the Australian Securities Exchange. The issuance com
Proteomics Appoints Growth Medics to Drive European Sales
Predictive diagnostics medical company Proteomics International Laboratories (ASX: PIQ), has engaged Growth Medics B.V., to assist with the identification and selection of EU alliance partners for its PromarkerD predictive test for diabetic kidney disease.
Proteomics International Laboratories Supports Root Rot Study With Biomarker Platform
Proteomics International Laboratories (ASX:PIQ) supported a study by Curtin University's Centre for Crop and Disease Management to analyze the understanding of root rot, also known as dieback, accordi
Proteomics International Laboratories (ASX:PIQ) Shareholders Have Earned a 26% CAGR Over the Last Five Years
Proteomics International Partners With University of Oxford to Advance Endometriosis Study
Predictive diagnostics specialist Proteomics International Laboratories (ASX: PIQ) has signed an agreement with the University of Oxford to acquire approximately 600 patient plasma samples for a study into endometriosis.
No Data